EVISA Glossary on | Contact EVISA | Sitemap | Home   
 Advanced search
The establishment of EVISA is funded by the EU through the Fifth Framework Programme (G7RT- CT- 2002- 05112).


Supporters of EVISA includes:



Medicinal Research Reviews


 

Status
active
Indexing
BIOBASE: Current Awareness in Biological Sciences (Elsevier); BIOSIS Previews (Thomson Reuters); CAS: Chemical Abstracts Service (CAS); CCR Database (Thomson Reuters); Chemical Abstracts Service/SciFinder (ACS); ChemInform (Wiley-VCH/FIZ Chemie); Chemistry Server Reaction Center (Thomson Reuters); ChemWeb (ChemIndustry.com); Current Contents: Life Sciences (Thomson Reuters);
Embase (Elsevier); Index Medicus/MEDLINE (NLM);
Journal Citation Reports/Science Edition (Thomson Reuters); MEDLINE (NLM); Reaction Citation Index (Thomson Reuters); Reference Update (Thomson Reuters); Science Citation Index (Thomson Reuters); Science Citation Index Expanded™ (Thomson Reuters); SCOPUS (Elsevier); SIIC Databases (Sociedad Iberoamericana de Informacion Cientifica); VINITI (All-Russian Institute of Science & Technological Information); Web of Science (Thomson Reuters);
Subject

Source type
Journal
Publisher
ISBN ISSN
0198-6325
E ISSN
1098-1128
First volume
1
Last volume
32+
Publish city
New York
Homepage
Description
The journal publishes timely, critical reviews of topics related to medicinal research, broadly defined, to which the authors have made significant contributions. Appropriate topics include, but are not limited to, the underlying pathophysiology of important diseases and disease vectors; therapeutic approaches to the treatment of various diseases; the properties of molecular targets for therapeutic agents; important new methodologies facilitating the search for therapies; genomics and proteomics; structure-activity correlations of drug series; the development of new imaging and diagnostic tools; drug metabolism; drug delivery; and chemical, pharmacological, pharmacokinetic, pharmacodynamic, and clinical characteristics of important drugs. Reviews are mainly solicited by the editors; however, voluntary contributions are also encouraged. In the latter case, potential authors are asked to contact the Editor-in-chief with an outline before beginning to write in order to avoid duplication of effort and to ensure suitability of the topic and the level of coverage.


Related links:









Imprint     Disclaimer

© 2003 - 2024 by European Virtual Institute for Speciation Analysis ( EVISA )